Home›People›Bryan Miller
BM

Bryan Miller

Executive officer at Ambagon Therapeutics.

Executive
Updated Oct 27, 2026·Latest SEC filing Jun 1, 2022·Suggest an edit

About Bryan Miller

Form D filings for Ambagon Therapeutics from 2021 to 2022 list Bryan Miller as executive officer.

Bryan Miller first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Bryan Miller in the role, so the role may have started earlier or lasted longer.

Ambagon Therapeutics Inc.
Executive officer
2021 – 2022 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.

Key Colleagues at Startups

The people Bryan Miller works with at each company, as listed on that company's latest Form D.

Ambagon Therapeutics Inc. · Form D/A, Jun 1, 2022
JS
Josh Seidenfeld
Executive officer
MA
PD
Peter Dudek
Director
RB
NP
Nancy Pryer
Executive officer
Christian Ottmann
Christian Ottmann
Co-Founder & Chief Executive Officer
AR
MM
Melissa McCracken
Partner, Nextech Invest and director
SC
Scott Clarke
Chief Executive Officer and director

Sources

  1. SECAmbagon Therapeutics Inc. Form D/A, filed Jun 1, 2022